Showing results (601-610 of 619) with videos related to
Sort By:
Pageof 62
American Journal of Industrial Medicine|July 25, 2008
Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control studyAdele Seniori Costantini, Alessandra Benvenuti, Paolo Vineis, et al.Gut|November 13, 2002
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient dataC Cammà, S Bruno, F Schepis, et al.Journal of Medicinal Chemistry|September 16, 2011
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Adeline Prêtre, Catherine Jorand-Lebrun, et al.Journal of Medicinal Chemistry|March 6, 2008
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Patrick Page, Marc Missotten, et al.Cancer|February 11, 2004
Breast carcinoma survival in Europe and the United StatesMilena Sant, Claudia Allemani, Franco Berrino, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Discovery of a novel series of potent S1P1 agonistsStefano Crosignani, Agnes Bombrun, David Covini, et al.Maturitas|August 23, 2002
Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-usersA R Genazzani, A Nicolucci, C Campagnoli, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic AcidsStefano Crosignani, Catherine Jorand-Lebrun, Gordon Campbell, et al.Chemmedchem|March 5, 2015
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacyAnna Quattropani, Wolfgang H B Sauer, Stefano Crosignani, et al.Pageof 62